Cargando…

Crucial role of T cells in NAFLD-related disease: A review and prospect

Nonalcoholic fatty liver disease (NAFLD) includes a series of hepatic manifestations, starting with liver steatosis and potentially evolving towards nonalcoholic steatohepatitis (NASH), fibrosis, cirrhosis or even hepatocellular carcinoma (HCC). Its incidence is increasing worldwide. Several factors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mao, Tianyu, Yang, Rui, Luo, Yi, He, Kang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705593/ https://www.ncbi.nlm.nih.gov/pubmed/36457551 http://dx.doi.org/10.3389/fendo.2022.1051076

Ejemplares similares

Immunotherapy for NAFLD and NAFLD-related hepatocellular carcinoma
por: Jeong, Seogsong, et al.
Publicado: (2023)

The crucial role and mechanism of insulin resistance in metabolic disease
por: Zhao, Xuefei, et al.
Publicado: (2023)

Major roles of kupffer cells and macrophages in NAFLD development
por: Park, Soo-Jeung, et al.
Publicado: (2023)

Overview and prospect of NAFLD: Significant roles of nutrients and dietary patterns in its progression or prevention
por: Mao, Tianyu, et al.
Publicado: (2023)

The role of FOXA family transcription factors in glucolipid metabolism and NAFLD
por: Yu, Chuchu, et al.
Publicado: (2023)

Role of NAFLD on the Health Related QoL Response to Lifestyle in Patients With Metabolic Syndrome: The PREDIMED Plus Cohort
por: Martínez-Urbistondo, Diego, et al.
Publicado: (2022)

Editorial: The NAFLD-MAFLD conundrum
por: Dalbeni, Andrea, et al.
Publicado: (2023)

Identification of ribosomal protein family as immune-cell-related biomarkers of NAFLD by bioinformatics and experimental analyses
por: Li, Gerui, et al.
Publicado: (2023)

Editorial: The roles and mechanisms of hepatokines, adipokines and myokines in the development of non-alcoholic fatty liver disease (NAFLD)
por: Lu, Yan
Publicado: (2022)

Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)
por: Rong, Li, et al.
Publicado: (2023)

Corrigendum: Role of NAFLD on the health related QoL response to lifestyle in patients with metabolic syndrome: The PREDIMED plus cohort
por: Martínez-Urbistondo, Diego, et al.
Publicado: (2023)

Pathophysiology of NAFLD and NASH in Experimental Models: The Role of Food Intake Regulating Peptides
por: Kořínková, L., et al.
Publicado: (2020)

Serum metabolomic profiling unveils distinct sex-related metabolic patterns in NAFLD
por: Fotakis, Charalambos, et al.
Publicado: (2023)

Crucial Role Reported for TSPO in Viability and Steroidogenesis is a Misconception. Commentary: Conditional Steroidogenic Cell-Targeted Deletion of TSPO Unveils a Crucial Role in Viability and Hormone-Dependent Steroid Formation
por: Selvaraj, Vimal, et al.
Publicado: (2016)

Too Much of a Good Thing? An Evolutionary Theory to Explain the Role of Ceramides in NAFLD
por: Poss, Annelise M., et al.
Publicado: (2020)

Cardiovascular and renal burdens among patients with MAFLD and NAFLD in China
por: Wang, Yuying, et al.
Publicado: (2022)

Comparative Study of Different Diets-Induced NAFLD Models of Zebrafish
por: Chen, Bo, et al.
Publicado: (2018)

Increased plasma genistein after bariatric surgery could promote remission of NAFLD in patients with obesity
por: Wang, Geng, et al.
Publicado: (2023)

Sensitivity to Thyroid Hormone Indices Are Closely Associated With NAFLD
por: Lai, Shuiqing, et al.
Publicado: (2021)

Editorial: Pharmacology and treatment methods for NAFLD in the context of diabetes
por: Abu-Farha, Mohamed, et al.
Publicado: (2022)

Clinical features and metabolic complications for non-alcoholic fatty liver disease (NAFLD) in youth with obesity
por: Barbieri, Emiliano, et al.
Publicado: (2023)

Baseline level and change trajectory of the triglyceride-glucose index in relation to the development of NAFLD: a large population-based cohort study
por: Wang, Yaqin, et al.
Publicado: (2023)

Human Genetics to Identify Therapeutic Targets for NAFLD: Challenges and Opportunities
por: Du, Xiaomi, et al.
Publicado: (2021)

Semaglutide ameliorates metabolism and hepatic outcomes in an NAFLD mouse model
por: Niu, Shu, et al.
Publicado: (2022)

Editorial: Secreted proteins as novel biomarkers and therapeutic targets in NAFLD
por: Xiong, Xuelian
Publicado: (2023)

Potential screening indicators for early diagnosis of NAFLD/MAFLD and liver fibrosis: Triglyceride glucose index–related parameters
por: Xue, Yan, et al.
Publicado: (2022)

Identification of biomarkers for the diagnosis of chronic kidney disease (CKD) with non-alcoholic fatty liver disease (NAFLD) by bioinformatics analysis and machine learning
por: Cao, Yang, et al.
Publicado: (2023)

Peripheral blood mononuclear cell mitochondrial copy number and adenosine triphosphate inhibition test in NAFLD
por: Lee, A-Hyeon, et al.
Publicado: (2022)

Comprehensive Transcriptome Profiling of NAFLD- and NASH-Induced Skeletal Muscle Dysfunction
por: Guo, Mingwei, et al.
Publicado: (2022)

Hunger & satiety signals: another key mechanism involved in the NAFLD pathway
por: López-Méndez, Iván, et al.
Publicado: (2023)

Global publication trends and research hotspots of the gut-liver axis in NAFLD: A bibliometric analysis
por: Yang, Shuangjie, et al.
Publicado: (2023)

Research Perspectives on the Regulation and Physiological Functions of FGF21 and its Association with NAFLD
por: Inagaki, Takeshi
Publicado: (2015)

Identification of Crucial Genes and Key Functions in Type 2 Diabetic Hearts by Bioinformatic Analysis
por: Huang, Xin, et al.
Publicado: (2022)

UFL1, a UFMylation E3 ligase, plays a crucial role in multiple cellular stress responses
por: Jiang, Qiang, et al.
Publicado: (2023)

Vitamin D improves hepatic steatosis in NAFLD via regulation of fatty acid uptake and β-oxidation
por: Du, Tingwan, et al.
Publicado: (2023)

A systematic review and meta-analysis of cohort studies on the potential association between NAFLD/MAFLD and risk of incident atrial fibrillation
por: Zhou, Ben‐Gang, et al.
Publicado: (2023)

Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis
por: Lian, Jingxuan, et al.
Publicado: (2021)

Circulating Ism1 Reduces the Risk of Type 2 Diabetes but not Diabetes-Associated NAFLD
por: Wang, Jiajia, et al.
Publicado: (2022)

Exploration of the core gene signatures and mechanisms between NAFLD and sarcopenia through transcriptomic level
por: Xu, Ziying, et al.
Publicado: (2023)

Glucokinase regulatory protein: a balancing act between glucose and lipid metabolism in NAFLD
por: Zhang, Ziqi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u6kecernd6h7k9cc0k3lv9vka4